Oncologists’ national appointment means greater support for local lymphoma and leukemia patients

Jeff Sharman, M.D., medical oncologist

Jeff Sharman, M.D., medical oncologist

Dedicated to his patients and the prospect of finding cures for cancer, Dr. Jeff Sharman, a medical oncologist practicing at Willamette Valley Cancer Institute and Research Center, was recently appointed associate chair of blood cancer research for US Oncology, the nation’s premier oncology services company.

By accepting this national appointment, those in Lane County will now have greater access to lymphoma and leukemia drugs through clinical trials, offering new hope for patients right here in our community.

“Our knowledge of the fundamental processes that cause cancer is accelerating faster than ever before,” Dr. Sharman says. “This is resulting in more treatment options for our patients that are more effective with fewer side effects. There’s probably more drugs in development for cancer than almost all other conditions combined.”

At Stanford where he completed his fellowship, Dr. Sharman’s research into new drugs for lymphoma gained international attention and received unique recognition from the American Society of Hematology. Dr. Sharman now has an active role in clinical trial development for WVCI. Patients are referred to WVCI for clinical trials from OHSU, MD Anderson and Stanford University.

Watch Dr. Sharman in this four-part video as he speaks to the Leukemia and Lymphoma Society about the history of cancer treatment and the outlook of what's to come.

To watch parts II-IV, click here.

Josh Kermisch
Posted July 20, 2011

Comments

  • maria July 21, 2011 4:43 AM

    Great job!  Very interesting and informative!

  • Sasha August 12, 2013 9:36 AM

    Congratulations. There are more treatment options now a days. Very informative post.
    Visit us: http://www.empowereddoctor.com/acute-lymphoblastic-leukemia

Add your comment

By submitting a comment you are agreeing to the Terms & Conditions